Test your business idea: Flemingsberg Science Award Startup open for applications

STARTUP is a competition for startups with a clear connection to Flemingsberg, either as students, residents or otherwise active in the area.

All ideas are welcome to participate in STARTUP as long as you compete with your own idea and the turnover and external equity is below SEK 1,000,000 at the time you submit to the competition. After that, we of course welcome you to continue working with the business idea, sales and any investments.

The competition closes March 7.

Read more

The Flemingsberg Science Award is a sub-competition to the national business plan competition Venture Cup. Venture Cup was launched in 1998 to support growth in Sweden. Since then, the concept has grown to include a successful process where participants receive help to develop their business ideas for tomorrow’s companies. Knowledgeable industry experts engage non-profit by providing feedback and development tips on all ideas submitted. In addition, the organization offers inspiration, training, guidance and the opportunity to create a solid network.

Read more about Venture Cup

 

 

 

Published On: 30 January 2023

  • Cecilia Bergh: “We’ll succeed – it just needs hard work”

    After almost 25 years’ concerted struggle to disseminate her successful eating disorder treatment, Cecilia Bergh wants to shift up a gear. Her goal is to digitalise her technique and turn the Mandometer support tool into a consumer product.

  • Chris Heister: “Everyone who has made this journey feels as though they’re fighting the system a bit.”

    Even if Chris Heister shifts down a gear when she leaves her role as council leader in Stockholm, she is unlikely be drawing on her pension any time soon. The class journey she has made from growing up in a countryside idyll, north of Stockholm, has given her a momentum that continually drives her forward.

  • Evren Alici set to make cancer a liveable illness

    A recent study could pave the way to treating a type of bone marrow cancer. The aim is to transform the cancer from being incurable to a disease that it is possible to live with. The research behind the study was conducted in Evren Alici’s group at Campus Flemingsberg.

  • Karin Mellström: “Co-operation is the key to success”

    After 10 years as a start-up, CellProtect Nordic Pharmaceuticals has taken a major step forward. Our patient and careful work is now bearing fruit, explains Karin Mellström, CEO and founder. Looking back on her career, she sums it up by saying: “I’d never been bored for a second!”

  • Matti Sällberg: “Vital to contribute facts to the debate”

    During the course of the pandemic, he has appeared on an almost daily basis in the morning papers or on the TV news. Matti Sällberg fast became an expert the media called for help explaining everything from vaccine development to the spread of infection.